Immunotherapy and Bladder Cancer
1 意见
• 06/16/23
0
0
嵌入
Researchers at Dana-Farber Cancer Institute are looking to expand treatment options for bladder cancer patients beyond surgery and chemotherapy. In what’s known as the BLASST trial, they’re adding in immunotherapy before any surgery takes place in muscle-invasive bladder cancer.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论